UPDATE - UBS Initiates Coverage on Wintrust Financial (WTFC) with a Buy; Back to the Future
Tweet
Share
E-mailGet Alerts WTFC Hot Sheet
Price: $152.67 +0.04%
Rating Summary:
10 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
10 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
UPDATE - UBS initiates coverage on Wintrust Financial (Nasdaq: WTFC) with a Buy rating. PT $36.
UBS analyst says, "Chicago opportunities knock: The company has restarted its growth engines and has been actively expanding its franchise across all business lines. We expect prudent acquisitions to continue alongside organic growth. The Chicago MSA offers significant possibilities to a company such as WTFC. Increased capital deployment could support additional assets of ~$4.5B and generate EPS 31% above our current 2012 estimate."
"Credit quality remains well managed: Asset quality has remained relatively well managed versus Midwest competitors and, even more specifically, against Chicago-based peers. We conservatively estimate that WTFC is more than 6.2% through the loss recognition phase of this cycle."
To See Ratings Summary & History on WTFC, Click Here
UBS analyst says, "Chicago opportunities knock: The company has restarted its growth engines and has been actively expanding its franchise across all business lines. We expect prudent acquisitions to continue alongside organic growth. The Chicago MSA offers significant possibilities to a company such as WTFC. Increased capital deployment could support additional assets of ~$4.5B and generate EPS 31% above our current 2012 estimate."
"Credit quality remains well managed: Asset quality has remained relatively well managed versus Midwest competitors and, even more specifically, against Chicago-based peers. We conservatively estimate that WTFC is more than 6.2% through the loss recognition phase of this cycle."
To See Ratings Summary & History on WTFC, Click Here
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DA Davidson Starts Everus (ECG) at Buy
- TD Cowen Assumes Maze Therapeutics (MAZE) at Buy
- TD Cowen Assumes Immunocore Holdings (IMCR) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
